Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mtDNA mutation load assessment in mesoangioblasts from adult mtDNA mutation carriers
NL-OMON42480Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Feb 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in Mitochondrial myopathies (MM) and Mitochondriopathy, sponsored by Erasmus MC. Primary endpoint: mtDNA mutation load in single mesoangioblasts and skeletal muscle. Started Feb 2016; status: active, not recruiting.
02
Conditions
Mitochondrial myopathies (MM)Mitochondriopathy
Beyond the preview
Go deeper on NL-OMON42480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42480.